Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy
Clinical trial NCT00674323 · COMPLETED
Trial details
- NCT number
- NCT00674323
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2009-05-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.